This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- President Xi Jinping reaffirmed China's commitment to market openness, pledging to boost imports of high-quality products and services while reducing restrictions on trade and investment.
- The Hang Seng Biotech Index plunged over 3%, leading a broader sell-off in Hong Kong as capital flows shifted toward U.S. markets and regional growth stocks faced renewed pressure.
- China will deepen cooperation in the Greater Bay Area (GBA), positioning the region as a hub for digital technology, artificial intelligence, and new models of economic partnership.
- The World Trade Organization (WTO) was highlighted as the "cornerstone" of international trade, with Xi calling for APEC members to resolve disputes through multilateral discussion rather than unilateral action.
Xi Jinping Champions "Open Regional Economy" in Shenzhen
Speaking at the APEC CEO Summit 2026 in Shenzhen, Chinese President Xi Jinping emphasized that China is accelerating its push toward greater market openness. He stressed the importance of preserving global supply chains and urged APEC member economies to strengthen partnerships based on shared benefits and common prosperity.
Xi highlighted that Beijing intends to reduce restrictions on trade and investment to foster a regional economy characterized by higher efficiency and fairness. He called for the WTO to remain at the core of the international trading system, signaling a push against protectionist trends and a commitment to multilateralism.
A central pillar of the address was the development of the Guangdong-Hong Kong-Macao Greater Bay Area. Xi noted that China will deepen cooperation within this cluster to pioneer new models for Asia-Pacific economic partnerships, particularly in the fields of digital technology and artificial intelligence.
Hong Kong Markets Under Pressure as Biotech Tumbles
Despite the optimistic rhetoric from the summit, Hong Kong-listed stocks faced significant headwinds on Wednesday. The Hang Seng Biotech Index fell by more than 3%, reflecting a sharp retreat in growth-oriented sectors. Investors appeared cautious as capital flows favored U.S. technology assets, leaving Asian markets to grapple with local valuation pressures.
Individual biotech heavyweights were hit hard, with WuXi Biologics (02269) seeing its shares decline as part of the broader sectoral downturn. The selling pressure extended to the wider Hang Seng Index, which dropped approximately 2.6%, threatening the critical 23,000-point threshold.
Technology giants also struggled to maintain footing. Alibaba (09988) saw its stock price slip below the HK$100 mark, while other major players like NetEase (09999) and Lenovo Group (00992) faced similar declines. Market analysts suggest that while the long-term outlook for the Greater Bay Area remains a focus, short-term volatility is being driven by shifting global interest rate expectations and regional profit-taking.
Innovation and Unity at the Core of APEC 2026
President Xi urged APEC members to address shared challenges through greater cooperation and unity, specifically pointing to the field of technological and scientific innovation. He stated that China stands ready to work with all parties to promote a "jointly prosperous Asia-Pacific region" through renewed confidence and resolve.
The summit is expected to culminate in the release of the Shenzhen Initiative, the first outcome document in the summit’s 30-year history to be issued in this format. The initiative is intended to consolidate the business community’s proposals on AI governance, digital economy cooperation, and sustainable development, aligning with China's broader strategic goals for the region.
Automated market updates written with AI from market data and news wire reports, published without human review.